Cargando…

Peer review in Clinical Pharmacology using the 8-D Assessment

The requirement for editors of clinical pharmacology journals to maintain an overview of the peer review process for manuscripts submitted can be facilitated by use of the 8-D Assessment. The 8-D Assessment comprises peer review criteria to determine if the:1. Design of the study, 2. Diagnoses emplo...

Descripción completa

Detalles Bibliográficos
Autor principal: Woodcock, Barry G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352955/
https://www.ncbi.nlm.nih.gov/pubmed/28218890
http://dx.doi.org/10.5414/CP202971
_version_ 1782515063864688640
author Woodcock, Barry G.
author_facet Woodcock, Barry G.
author_sort Woodcock, Barry G.
collection PubMed
description The requirement for editors of clinical pharmacology journals to maintain an overview of the peer review process for manuscripts submitted can be facilitated by use of the 8-D Assessment. The 8-D Assessment comprises peer review criteria to determine if the:1. Design of the study, 2. Diagnoses employed, 3. Drug molecules involved, 4. Dosages applied, 5. Data collected, 6. Discussion of the findings, 7. Deductions made, and 8. Documentation are in accord with the objectives of the study and meet the requirements of evidence-based medicine. This tool, although easy to apply, requires a high level of clinical pharmacology expertise, especially in the fields of drug disposition, pharmacokinetics, and drug action.
format Online
Article
Text
id pubmed-5352955
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dustri-Verlag Dr. Karl Feistle
record_format MEDLINE/PubMed
spelling pubmed-53529552017-03-21 Peer review in Clinical Pharmacology using the 8-D Assessment Woodcock, Barry G. Int J Clin Pharmacol Ther Viewpoint The requirement for editors of clinical pharmacology journals to maintain an overview of the peer review process for manuscripts submitted can be facilitated by use of the 8-D Assessment. The 8-D Assessment comprises peer review criteria to determine if the:1. Design of the study, 2. Diagnoses employed, 3. Drug molecules involved, 4. Dosages applied, 5. Data collected, 6. Discussion of the findings, 7. Deductions made, and 8. Documentation are in accord with the objectives of the study and meet the requirements of evidence-based medicine. This tool, although easy to apply, requires a high level of clinical pharmacology expertise, especially in the fields of drug disposition, pharmacokinetics, and drug action. Dustri-Verlag Dr. Karl Feistle 2017-03 2017-02-14 /pmc/articles/PMC5352955/ /pubmed/28218890 http://dx.doi.org/10.5414/CP202971 Text en © Dustri-Verlag Dr. K. Feistle http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Viewpoint
Woodcock, Barry G.
Peer review in Clinical Pharmacology using the 8-D Assessment
title Peer review in Clinical Pharmacology using the 8-D Assessment
title_full Peer review in Clinical Pharmacology using the 8-D Assessment
title_fullStr Peer review in Clinical Pharmacology using the 8-D Assessment
title_full_unstemmed Peer review in Clinical Pharmacology using the 8-D Assessment
title_short Peer review in Clinical Pharmacology using the 8-D Assessment
title_sort peer review in clinical pharmacology using the 8-d assessment
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352955/
https://www.ncbi.nlm.nih.gov/pubmed/28218890
http://dx.doi.org/10.5414/CP202971
work_keys_str_mv AT woodcockbarryg peerreviewinclinicalpharmacologyusingthe8dassessment